Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Infectious Diseases Operative Unit, Santa Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy.
BMC Med. 2022 May 2;20(1):144. doi: 10.1186/s12916-022-02347-8.
Persistent fever, defined as fever lasting for 7 days or more at first medical evaluation, has been hardly investigated as a separate clinical entity in the tropics. This study aimed at exploring the frequencies and diagnostic predictors of the ubiquitous priority (i.e., severe and treatable) infections causing persistent fever in the tropics.
In six different health settings across four countries in Africa and Asia (Sudan, Democratic Republic of Congo [DRC], Nepal, and Cambodia), consecutive patients aged 5 years or older with persistent fever were prospectively recruited from January 2013 to October 2014. Participants underwent a reference diagnostic workup targeting a pre-established list of 12 epidemiologically relevant priority infections (i.e., malaria, tuberculosis, HIV, enteric fever, leptospirosis, rickettsiosis, brucellosis, melioidosis, relapsing fever, visceral leishmaniasis, human African trypanosomiasis, amebic liver abscess). The likelihood ratios (LRs) of clinical and basic laboratory features were determined by pooling all cases of each identified ubiquitous infection (i.e., found in all countries). In addition, we assessed the diagnostic accuracy of five antibody-based rapid diagnostic tests (RDTs): Typhidot Rapid IgM, Test-it Typhoid IgM Lateral Flow Assay, and SD Bioline Salmonella typhi IgG/IgM for Salmonella Typhi infection, and Test-it Leptospira IgM Lateral Flow Assay and SD Bioline Leptospira IgG/IgM for leptospirosis.
A total of 1922 patients (median age: 35 years; female: 51%) were enrolled (Sudan, n = 667; DRC, n = 300; Nepal, n = 577; Cambodia, n = 378). Ubiquitous priority infections were diagnosed in 452 (23.5%) participants and included malaria 8.0% (n = 154), tuberculosis 6.7% (n = 129), leptospirosis 4.0% (n = 77), rickettsiosis 2.3% (n = 44), enteric fever 1.8% (n = 34), and new HIV diagnosis 0.7% (n = 14). The other priority infections were limited to one or two countries. The only features with a positive LR ≥ 3 were diarrhea for enteric fever and elevated alanine aminotransferase level for enteric fever and rickettsiosis. Sensitivities ranged from 29 to 67% for the three RDTs targeting S. Typhi and were 9% and 16% for the two RDTs targeting leptospirosis. Specificities ranged from 86 to 99% for S. Typhi detecting RDTs and were 96% and 97% for leptospirosis RDTs.
Leptospirosis, rickettsiosis, and enteric fever accounted each for a substantial proportion of the persistent fever caseload across all tropical areas, in addition to malaria, tuberculosis, and HIV. Very few discriminative features were however identified, and RDTs for leptospirosis and Salmonella Typhi infection performed poorly. Improved field diagnostics are urgently needed for these challenging infections.
NCT01766830 at ClinicalTrials.gov.
在热带地区,持续性发热(定义为首次就诊时发热持续 7 天或以上)几乎没有被作为一个独立的临床实体进行研究。本研究旨在探索在热带地区普遍存在的(即严重且可治疗的)感染性优先疾病导致持续性发热的频率和诊断预测因素。
在六个不同的卫生机构中,来自四个国家(苏丹、刚果民主共和国[DRC]、尼泊尔和柬埔寨)的年龄在 5 岁或以上的持续性发热患者,于 2013 年 1 月至 2014 年 10 月期间连续纳入。参与者接受了参考诊断检查,针对预先确定的 12 种具有流行病学相关性的优先感染(即疟疾、结核病、HIV、肠热病、钩端螺旋体病、立克次体病、布鲁氏菌病、类鼻疽、回归热、内脏利什曼病、非洲锥虫病、阿米巴肝脓肿)。通过汇总每个确定的普遍感染(即所有国家均发现的感染)的所有病例,确定临床和基本实验室特征的比值比(LR)。此外,我们评估了五种基于抗体的快速诊断检测(RDT)的诊断准确性:Typhidot Rapid IgM、Test-it Typhoid IgM 侧向流动检测、SD Bioline 伤寒沙门氏菌 IgG/IgM 用于检测伤寒沙门氏菌感染,以及 Test-it Leptospira IgM 侧向流动检测和 SD Bioline Leptospira IgG/IgM 用于检测钩端螺旋体病。
共纳入 1922 例患者(中位数年龄:35 岁;女性:51%)(苏丹,n=667;DRC,n=300;尼泊尔,n=577;柬埔寨,n=378)。452 例(23.5%)患者诊断为普遍存在的优先感染,包括疟疾 8.0%(n=154)、结核病 6.7%(n=129)、钩端螺旋体病 4.0%(n=77)、立克次体病 2.3%(n=44)、肠热病 1.8%(n=34)和新诊断的 HIV 感染 0.7%(n=14)。其他优先感染仅限于一个或两个国家。唯一具有阳性 LR≥3 的特征是肠热病的腹泻和肠热病和立克次体病的丙氨酸氨基转移酶水平升高。三种针对 S. Typhi 的 RDT 的敏感性范围为 29%至 67%,两种针对钩端螺旋体病的 RDT 的敏感性为 9%和 16%。S. Typhi 检测 RDT 的特异性范围为 86%至 99%,钩端螺旋体病 RDT 的特异性为 96%和 97%。
除疟疾、结核病和 HIV 外,钩端螺旋体病、立克次体病和肠热病在所有热带地区的持续性发热病例中也占很大比例。然而,几乎没有发现有鉴别意义的特征,并且针对钩端螺旋体病和伤寒沙门氏菌感染的 RDT 表现不佳。迫切需要改进针对这些具有挑战性的感染的现场诊断方法。
NCT01766830 在 ClinicalTrials.gov 上注册。